Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

22

Number of overlapping holdings

16.2%

% of XBI's 136 holdings also in GNOM

53.7%

% of GNOM's 41 holdings also in XBI

Overlap by Weight
Sector Drift (XBI minus GNOM)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in XBI
Weight
in GNOM
Overlap
NATERA INC 3.5% 5.4% 3.5%
SAREPTA THERAPEUTICS INC 2.7% 3.6% 2.7%
ALNYLAM PHARMACEUTICALS INC 2.5% 3.2% 2.5%
BIOMARIN PHARMACEUTICAL INC 2.1% 3.6% 2.1%
GILEAD SCIENCES INC 3.0% 2.0% 2.0%

Position Highlights (Non-Overlapping Exposures)
XBI Overweight Relative to GNOM
INCYTE CORP 2.9%
UNITED THERAPEUTICS CORP 2.9%
ADVENTRX PHARMACEUTICALS INC 2.8%
NEUROCRINE BIOSCIENCES INC 2.8%
INSMED INC 2.6%
EXACT SCIENCES CORP 2.5%
ABBVIE INC 2.4%
AMGEN INC 2.2%
MADRIGAL PHARMACEUTICALS, INC. 2.2%
BIOGEN IDEC INC 2.1%
XBI Underweight Relative to GNOM
ENI SPA-SPONSORED ADR -7.7%
VERACYTE INC -4.5%
BIO-TECHNE CORPORATION -4.2%
QIAGEN NV -4.2%
BIONTECH SE SPONSORED ADR -4.1%
AGILENT TECHNOLOGIES INC -4.0%
ILLUMINA INC -3.8%
ARROWHEAD PHARMACEUTICALS, INC. -3.6%
LEGEND BIOTECH CORPORATION SPONSORED -3.1%
BEAM THERAPEUTICS, INC. -2.8%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY